RESEARCHER PROFILE
Diego Dal Ben
← Back to Università di Camerino
D
Università di Camerino
Diego Dal Ben works in Adenosine and Purinergic Signaling, Receptor Mechanisms and Signaling, Biochemical and Molecular Research, Synthesis and biological activity, Synthesis and Characterization of Heterocyclic Compounds. Recorded institutional associations include Università di Camerino.
149Publications
4,657Citations
28H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
The P2X7 Receptor in Infection and Inflammation
2017 · 1,259 citationsEfficacy of acetylcholinesterase inhibitors in Alzheimer's disease
2020 · 1,130 citationsToward the rational design of protein kinase casein kinase-2 inhibitors
2002 · 155 citationsP2X7 Receptor as a Therapeutic Target
2016 · 111 citationsFragment optimization for GPCRs by molecular dynamics free energy calculations: Probing druggable subpockets of the A 2A adenosine receptor binding site
2017 · 61 citationsDesign, synthesis and evaluation in an LPS rodent model of neuroinflammation of a novel 18F-labelled PET tracer targeting P2X7
2017 · 60 citationsInnovative functional cAMP assay for studying G protein-coupled receptors: application to the pharmacological characterization of GPR17
2011 · 56 citations8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands
2009 · 55 citationsPyrazolo[1,5-c]quinazoline derivatives and their simplified analogues as adenosine receptor antagonists: Synthesis, structure–affinity relationships and molecular modeling studies
2012 · 55 citationsA2A Adenosine Receptor and its Modulators: Overview on a Druggable GPCR and on Structure-Activity Relationship Analysis and Binding Requirements of Agonists and Antagonists
2008 · 53 citationsAdenosine Receptors as Neuroinflammation Modulators: Role of A1 Agonists and A2A Antagonists
2020 · 52 citationsInteraction Model for Anthracycline Activity against DNA Topoisomerase II
2004 · 48 citationsMedicinal Chemistry of P2X Receptors: Agonists and Orthosteric Antagonists
2015 · 48 citationsPurinergic P2X receptors: Structural models and analysis of ligand-target interaction
2014 · 45 citationsThe G Protein‐Coupled Receptor GPR17: Overview and Update
2016 · 45 citationsUpdate on novel purinergic P2X3 and P2X2/3 receptor antagonists and their potential therapeutic applications
2019 · 44 citationsDNA Topoisomerase II Structures and Anthracycline Activity: Insights into Ternary Complex Formation
2007 · 43 citationsEvidence for the Existence of a Specific G Protein‐Coupled Receptor Activated by Guanosine
2011 · 43 citationsAdenosine Receptor Modeling: What Does the A2A Crystal Structure Tell Us?
2010 · 41 citationsNeuroprotective potential of adenosine A1 receptor partial agonists in experimental models of cerebral ischemia
2019 · 38 citationsAmide bond direction modulates G-quadruplex recognition and telomerase inhibition by 2,6 and 2,7 bis-substituted anthracenedione derivatives
2007 · 36 citationsN6-Methoxy-2-alkynyladenosine Derivatives as Highly Potent and Selective Ligands at the Human A3Adenosine Receptor
2007 · 36 citationsHighlights on the Development of A2A Adenosine Receptor Agonists and Antagonists
2006 · 36 citationsThe 1,2,4-Triazolo[4,3-a]pyrazin-3-one as a Versatile Scaffold for the Design of Potent Adenosine Human Receptor Antagonists. Structural Investigations to Target the A2AReceptor Subtype
2017 · 35 citationsThe aminopyridine-3,5-dicarbonitrile core for the design of new non-nucleoside-like agonists of the human adenosine A2B receptor
2018 · 35 citationsSynthesis and Biological Evaluation of 2-Alkynyl-N6-methyl-5′-N-methylcarboxamidoadenosine Derivatives as Potent and Highly Selective Agonists for the Human Adenosine A3Receptor
2009 · 34 citationsAdenosine A2A Receptor Antagonists: New 8‐Substituted 9‐Ethyladenines as Tools for in vivo Rat Models of Parkinson's Disease
2009 · 33 citationsAntiviral Properties of Deazaadenine Nucleoside Derivatives
2006 · 29 citationsMolecular modeling study on potent and selective adenosine A3 receptor agonists
2010 · 27 citationsExploring the 7-oxo-thiazolo[5,4-d]pyrimidine core for the design of new human adenosine A3 receptor antagonists. Synthesis, molecular modeling studies and pharmacological evaluation
2015 · 26 citationsP2X3 Receptor Ligands: Structural Features and Potential Therapeutic Applications
2021 · 26 citationsSimulation and comparative analysis of binding modes of nucleoside and non-nucleoside agonists at the A2B adenosine receptor
2013 · 25 citationsAntiproliferative Evaluation of Isofuranodiene on Breast and Prostate Cancer Cell Lines
2014 · 24 citationsModifications on the Amino-3,5-dicyanopyridine Core To Obtain Multifaceted Adenosine Receptor Ligands with Antineuropathic Activity
2019 · 23 citationsDifferent efficacy of adenosine and NECA derivatives at the human A3 adenosine receptor: Insight into the receptor activation switch
2013 · 22 citationsNovel potent and highly selective human A3 adenosine receptor antagonists belonging to the 4-amido-2-arylpyrazolo[3,4-c]quinoline series: Molecular docking analysis and pharmacological studies
2008 · 22 citationsDesign, synthesis, and biological evaluation of new mitonafide derivatives as potential antitumor drugs
2008 · 22 citationsSynthesis, structure–affinity relationships, and molecular modeling studies of novel pyrazolo[3,4-c]quinoline derivatives as adenosine receptor antagonists
2011 · 22 citationsAntioxidant-Conjugated 1,2,4-Triazolo[4,3-a]pyrazin-3-one Derivatives: Highly Potent and Selective Human A2A Adenosine Receptor Antagonists Possessing Protective Efficacy in Neuropathic Pain
2019 · 22 citations1,2,4-Triazolo[1,5-a]quinoxaline derivatives and their simplified analogues as adenosine A3 receptor antagonists. Synthesis, structure–affinity relationships and molecular modeling studies
2014 · 22 citationsImidazo[1,2-a]pyrazin-8-amine core for the design of new adenosine receptor antagonists: Structural exploration to target the A3 and A2A subtypes
2016 · 20 citationsPurinergic Ligands as Potential Therapeutic Tools for the Treatment of Inflammation-Related Intestinal Diseases
2018 · 20 citationsComparison and optimization of transient transfection methods at human astrocytoma cell line 1321N1
2011 · 19 citationsAdenine-Based Acyclic Nucleotides as Novel P2X 3 Receptor Ligands
2009 · 19 citationsEmerging Roles of Purinergic Signaling in Diabetes
2018 · 19 citationsNew potent and selective A1 adenosine receptor antagonists as potential tools for the treatment of gastrointestinal diseases
2018 · 19 citationsGPR17 receptor modulators and their therapeutic implications: review of recent patents
2019 · 19 citationsThe Anti-Inflammatory and Pain-Relieving Effects of AR170, an Adenosine A3 Receptor Agonist, in a Rat Model of Colitis
2020 · 19 citationsNeuropeptide S Receptor: Recent Updates on Nonpeptide Antagonist Discovery
2011 · 18 citationsExploring the 2- and 5-positions of the pyrazolo[4,3-d]pyrimidin-7-amino scaffold to target human A1 and A2A adenosine receptors
2016 · 18 citations
